FOR IMMEDIATE RELEASE
March 23, 2020 ANN ARBOR, MI
Genomenon® announced today that the University of California Santa Cruz (UCSC) Genome Browser, an open-sourced genetic knowledge base, has integrated links to Genomenon’s Mastermind® Genomic Search Engine into its platform to accelerate variant curation for genomic analysis.
The UCSC Genome Browser provides free, public access to genome assemblies, allowing researchers and clinicians the opportunity to search the genomic data of humans and many other species. Academics and researchers have been utilizing this interactive suite of tools, evidence, and downloadable data files for nearly 20 years.
Genomenon’s Mastermind is the world’s first genomic search engine, which connects patient’s genomic data with evidence from the scientific literature, a key requirement in analyzing a patient’s DNA in precision medicine for cancer and genetic diseases. Genomenon uses A.I. and machine learning to index the medical literature for the scientific evidence that ties genomic data to specific diseases, and presents them in a clinical context within Mastermind to accelerate patient diagnosis.
With the Mastermind integration, researchers have at their fingertips the most comprehensive list of aggregated evidence for any gene, variant, or position for all diseases. UCSC users will be able to quickly access the genomic evidence associated with human variants, shortening the search time required to interpret a variant and assess its pathogenicity.
"We’re excited about UCSC Genome Browsers’ broad reach into genetic research and clinical communities”, said Dr. Mark Kiel, Genomenon co-founder and Chief Science Officer. “Mastermind is becoming a regular resource for researchers, and UCSC added the Mastermind data track to provide a direct line-of-sight into the empirical evidence supporting their variant interpretation."
For step by step instructions on how to get to Mastermind from the UCSC Genome Browser, read our blog post.
Genomenon is a leading genomic intelligence company transforming patient care by uncovering the genomic drivers of genetic disease and cancer. By combining the power of AI built on the world’s premier genomic data set with genomic expertise, the company simplifies complex genetic data into actionable insights. Genomenon's integrated software, data, and services solutions empower clients with advanced patient diagnosis and precision medicine development.